Loading...
Variant constraint by mRNA vaccines
The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants.
Na minha lista:
| Udgivet i: | Nat Rev Immunol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8034506/ https://ncbi.nlm.nih.gov/pubmed/33837367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41577-021-00548-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|